![Tomohiro Anzai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tomohiro Anzai
Directeur des opérations chez
Fast Track Initiative, Inc.
Profil
Tomohiro Anzai currently works at AccuRna, Inc., as Director, Braizon Therapeutics, Inc., as Outside Director, Alivexis, Inc., as Director, PuREC KK, as Outside Director, and Fast Track Initiative Inc, as COO and Managing Partner.
Dr. Anzai also formerly worked at Modalis Therapeutics Corp., as Director.
Dr. Anzai received his graduate degree and doctorate degree from the University of Tokyo.
Postes actifs de Tomohiro Anzai
| Sociétés | Poste | Début |
|---|---|---|
Fast Track Initiative, Inc.
 Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative invests in companies located in Japan and the United States. The firm targets companies operating in the fields of the life science community including therapeutics, diagnostics, digital health, healthcare services, and more sectors. It provides financing for seed and early stages capital requirements. It also makes follow-on investments. | Directeur des opérations | - |
AccuRna, Inc.
 AccuRna, Inc. BiotechnologyHealth Technology Researches and develops nucleic acid-based drugs using drug delivery system technologies | Directeur/Membre du Conseil | - |
Modulus Discovery, Inc.
 Modulus Discovery, Inc. BiotechnologyHealth Technology Engages in development of drugs | Directeur/Membre du Conseil | - |
Braizon Therapeutics, Inc.
 Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drugs | Directeur/Membre du Conseil | - |
PuREC KK
 PuREC KK BiotechnologyHealth Technology Engages in research and development of cell therapy utilizing cellular function | Directeur/Membre du Conseil | - |
Anciens postes connus de Tomohiro Anzai
| Sociétés | Poste | Fin |
|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Directeur/Membre du Conseil | - |
Formation de Tomohiro Anzai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative invests in companies located in Japan and the United States. The firm targets companies operating in the fields of the life science community including therapeutics, diagnostics, digital health, healthcare services, and more sectors. It provides financing for seed and early stages capital requirements. It also makes follow-on investments. | Finance |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology Researches and develops nucleic acid-based drugs using drug delivery system technologies | Health Technology |
Braizon Therapeutics, Inc.
Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drugs | Commercial Services |
Modulus Discovery, Inc.
Modulus Discovery, Inc. BiotechnologyHealth Technology Engages in development of drugs | Health Technology |
PuREC KK
PuREC KK BiotechnologyHealth Technology Engages in research and development of cell therapy utilizing cellular function | Health Technology |
Modalis Therapeutics Corp.
 Modalis Therapeutics Corp. BiotechnologyHealth Technology Develops transformative therapeutics for diseases which are caused by malfunctioning of genes | Health Technology |
Choisissez Zonebourse 
